538
Views
15
CrossRef citations to date
0
Altmetric
Review

The Mediterranean Diet And Cardioprotection: Historical Overview And Current Research

& ORCID Icon
Pages 805-815 | Published online: 27 Sep 2019

References

  • Willett WC, Sacks F, Trichopoulou A, et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr. 1995;61(6):1402S–1406S. doi:10.1093/ajcn/61.6.14027754995
  • Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr. 2010;92:1189–1196. doi:10.3945/ajcn.2010.2967320810976
  • Schwingshackl L, Schwedhelm C, Galbete C, Hoffmann G. Adherence to mediterranean diet and risk of cancer: an updated systematic review and meta-analysis. Nutrients. 2017;9(10):1063 Published 2017 Sep 26. doi:10.3390/nu9101063
  • Davis C, Bryan J, Hodgson J, Murphy K. Definition of the mediterranean diet; a literature review. Nutrients. 2015;7(11):9139–9153. Published 2015 Nov 5. doi:10.3390/nu711545926556369
  • Available from: https://ich.unesco.org/en/RL/mediterranean-diet-00884. Accessed 911, 2019.[webpage on the Internet].
  • Keys A, Blackburn H, Menotti A, et al. Coronary heart disease in seven countries. Circulation. 1970;41(suppl 1):1–211.
  • Garnsey P. Food and Society in Classical Antiquity. Cambridge University Press; 1999.
  • Seymour TD. Life in Homeric Age. The MacMillan Co; 1907:208–234.
  • Waterlow JC. Diet of the classical period of Greece and Rome. Eur J Clin Nutr. 1989;43(Suppl.2):3–12.2689162
  • Craik E. Hippokratic diaita In: Wilkins J, Harvey D, Dobson M, editors. Food in Antiquity. Exeter, UK: University of Exeter Press; 1995:343–358.
  • Skiadas PK, Lascaratos JG. Dietetics in ancient Greek philosophy: plato’s concepts of healthy diet. Eur J Clin Nutr. 2001;55(7):532–537. doi:10.1038/sj.ejcn.160117911464226
  • Castelvetro G. The Fruit, Herbs & Vegetables of Italy. London: Viking; 1989.
  • Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the framingham study. Ann Intern Med. 1971;74:1–12. doi:10.7326/0003-4819-74-1-15539274
  • McGill HC. The relationship of dietary cholesterol to serum cholesterol concentration and to atherosclerosis in man. Am J Clin Nutr. 1979;32:2664–2702.05. doi:10.1093/ajcn/32.12.2664389024
  • Gordon T. The diet-heart idea: outline of a history. Am J Epidemiol. 1988;127:220–225. doi:10.1093/oxfordjournals.aje.a1147983276165
  • Allbaugh LG. Crete — A Case Study of an Underdeveloped Area. Princeton, NJ: Princeton University Press; 1953.
  • Keys A, Menotti A, Karvonen MJ, et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 1986;124(6):903–915. doi:10.1093/oxfordjournals.aje.a1144803776973
  • Cresta M, Ledermann S, Garnier A, Lombardo E, Lacouply G. Etude des Consommations alimentaires des Populations de onze Régions de la Communauté Européenne en vue de la Détermination des Niveaux de Contamination radioactive. Rapport EUR 4218f (1969). Available from: http://aei.pitt.edu/91957/1/4218_f.pdf. Accessed September 11, 2019.
  • Dayton S, Pearce ML, Hashimoto S, Dixon WJ, Tomiyasu U. A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation. 1969;40(suppl II): II-1–II-63. doi:10.1161/01.CIR.40.1S2.II-1
  • Leren P. The oslo diet-heart study. eleven-year report. Circulation. 1970;42:935–942. doi:10.1161/01.cir.42.4.6255477261
  • Turpeinen O, Karvonen MJ, Pekkarinen M, Miettinen M, Elosuo R, Paavilainen E. Dietary prevention of coronary heart disease: the finnish mental hospital study. Int J Epidemiol. 1979;8:99–118. doi:10.1093/ije/8.2.99393644
  • Burr M, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish and fibre intakes on death and reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2(8666):757–761. doi:10.1016/s0140-6736(89)92010-22571009
  • de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the lyon diet heart study. Circulation. 1999;99(6):779–785. doi:10.1161/01.cir.99.6.7799989963
  • Singh RB, Dubnov G, Niaz MA, et al. Effect of an Indo-mediterranean diet on progression of coronary artery disease in high risk patients (Indo-mediterranean diet heart study): a randomised single-blind trial. Lancet. 2002;360:1455–1461. doi:10.1016/S0140-6736(02)11472-312433513
  • GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet. 1999;354:447–455. doi:10.1016/S0140-6736(99)00434-110465168
  • Yokoyama M, Origasa H, Matsuzaki M, et al. Japan EPA lipid intervention study (JELIS) investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (jelis): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090–1098. doi:10.1016/S0140-6736(07)60527-317398308
  • Abdelhamid AS, Martin N, Bridges C, et al. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018;7:CD012345.30019767
  • Massaro M, Scoditti E, Carluccio MA, Montinari MR, De Caterina R. Omega–3 fatty acids, inflammation and angiogenesis: nutrigenomic effects as an explanation for anti-atherogenic and anti-inflammatory effects of fish and fish oils. J Nutrigenet Nutrigenomics. 2008;1:4–23. doi:10.1159/00010987119918111
  • Brown BG, Zhao X-Q, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583–1592. doi:10.1056/NEJMoa01109011757504
  • Meade T, Sleight P, Collins R, et al.MRC/BHF heart protection study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J. 1999;20(10):725–741. doi:10.1053/euhj.1998.135010329064
  • Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a mediterranean diet. N Engl J Med. 2013;368:1279–1290. doi:10.1056/NEJMoa120030323432189
  • Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378(25):e34. doi:10.1056/NEJMc171158329897866
  • Babio N, Toledo E, Estruch R, et al. Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial. Cmaj. 2014;186:E649–E657. doi:10.1503/cmaj.14076425316904
  • Salas-Salvadó J, Bulló M, Babio N, et al. Reduction in the incidence of type 2 diabetes with the mediterranean diet: results of the PREDIMED-reus nutrition intervention randomized trial [published correction appears in diabetes care. 2018 Oct;41(10):2259-2260]. Diabetes Care. 2010;34(1):14–19. doi:10.2337/dc10-128820929998
  • Doménech M, Roman P, Lapetra J, et al. Mediterranean diet reduces 24 hr ambulatory blood pressure, blood glucose, and lipids: one-year randomized, clinical trial. Hypertension. 2014;64:69–76. doi:10.1161/HYPERTENSIONAHA.113.0335324799608
  • Toledo E, Salas-Salvadó J, Donat-Vargas C, et al. Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial. JAMA Intern Med. 2015;175:1752–1760. doi:10.1001/jamainternmed.2015.483826365989
  • Papadaki A, Martínez-González MÁ, Alonso-Gómez A, et al. Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial. Eur J Heart Fail. 2017;19:1179–1185. doi:10.1002/ejhf.75028133855
  • Ruiz-Canela M, Zazpe I, Shivappa N, et al. Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardiovascular risk from the PREDIMED (PREvención con DIeta MEDiterránea) trial. Br J Nutr. 2015;113:984–995. doi:10.1017/S000711451400440125720588
  • Medina-Remón A, Casas R, Tressserra-Rimbau A, et al. Polyphenol intake from a mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a substudy of the PREDIMED trial. Br J Clin Pharmacol. 2016;83(1):114–128. doi:10.1111/bcp.1298627100393
  • Dinu M, Pagliai G, Casini A, Sofi F. Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr. 2018;72(1):30–43. Epub 2017 May 10. doi:10.1038/ejcn.2017.5828488692
  • Thompson RC, Allam AH, Lombardi GP, et al. Atherosclerosis across 4000 years of human history: the horus study of four ancient populations. Lancet. 2013;381:1211–1222. doi:10.1016/S0140-6736(13)60598-X23489753
  • Allam AH, Thompson RC, Wann LS, et al. Atherosclerosis in ancient Egyptian mummies: the horus study. JACC Cardiovasc Imaging. 2011;4:315–327. doi:10.1016/j.jcmg.2011.02.00221466986
  • Thompson RC, Allam AH, Zink AR, et al. Computed tomographic evidence of atherosclerosis in the mummified remains of humans from around the world. Glob Heart. 2014;9(2):187–196. ISSN 2211-8160. doi:10.1016/j.gheart.2014.03.245525667088
  • Allam AH, Mandour Ali MA, Wann LS, et al. Atherosclerosis in ancient and modern Egyptians: the horus study. Glob Heart. 2014;9(2):197–202. doi:10.1016/j.gheart.2014.03.245425667089
  • David AR, Kershaw A, Heagerty A. Atherosclerosis and diet in ancient Egypt. The Lancet. 2010;375(9716):718–719. doi:10.1016/S0140-6736(10)60294-2
  • Thomas GS, Wann LS, Allam AH, et al. Why did ancient people have atherosclerosis? From autopsies to computed tomography to potential causes. Glob Heart. 2014;9(2):229–237. ISSN 2211-8160. doi:10.1016/j.gheart.2014.04.00225667093
  • Friedman M, Friedland GW. Medicine’s 10 Greatest Discoveries. New Haven (CT): Yale University Press; 1998.
  • Anichkov NN. Experimental arteriosclerosis in animals In: Cowdry EV, editor. Arteriosclerosis: A Survey of the Problem. New York: MacMillan Publishing; 1933:271–322.
  • Anichkov NN. A history of experimentation on arterial atherosclerosis in animals In: Blumenthal HT, editor. Cowdry’s Arteriosclerosis: A Survey of the Problem. 2nd ed. Springfield, (IL): Charles C. Thomas Publishing; 1967:21–46.
  • Dock W. Research in arteriosclerosis; the first fifty years. Ann Intern Med. 1958;49:699–707. doi:10.7326/0003-4819-49-3-69913571855
  • Anitschkow NN, Wolkoff KG, Kikaion EE, Pozharisski KM. Compensatory adjustments in the structure of coronary arteries of the heart with stenotic atherosclerosis. Circulation. 1964;29:447–455. doi:10.1161/01.cir.29.1.414128833
  • Ross R, Harker L. Hyperlipidemia and atherosclerosis. Science. 1976;193:1094–1100. doi:10.1126/science.822515822515
  • Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143. doi:10.1161/hc0902.10435311877368
  • Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–874. doi:10.1038/nature0113112490960
  • Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med. 2008;263:517–527. doi:10.1111/j.1365-2796.2008.01965.x18410595
  • Virchow R. Cellular Pathology. London, United Kingdom: John Churchill; 1858.
  • Ross R, Glomset JA. The pathogenesis of atherosclerosis I. N Engl J Med. 1976;295(7):369–377. doi:10.1056/NEJM197608122950707819830
  • Ross R, Glomset JA. The pathogenesis of atherosclerosis II. N Engl J Med. 1976;295(8):420–425. doi:10.1056/NEJM197608192950805778621
  • Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991–1045. doi:10.1146/annurev.iy.12.040194.0050158011301
  • Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity. 2013;38(6):1092–1104. doi:10.1016/j.immuni.2013.06.00923809160
  • Liu D, Zeng X, Li X, Mehta JL, Wang X. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases. Basic Res Cardiol. 2018;113:5. doi:10.1007/s00395-017-0663-929224086
  • Abderrazak A, Couchie D, Mahmood DF, et al. Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2. Ki mice fed a high-fat diet. Circulation. 2015;131(12):1061–1070. doi:10.1161/CIRCULATIONAHA.114.01373025613820
  • Libby P, Brendan M. Everett novel antiatherosclerotic therapies. Arterioscler Thromb Vasc Biol. 2019;39:538–545. doi:10.1161/ATVBAHA.118.31095830816799
  • Lopez-Garcia E, Rodriguez-Artalejo F, Li TY, et al. The mediterranean-style dietary pattern and mortality among men and women with cardiovascular disease. Am J Clin Nutr. 2014;99(1):172–180. doi:10.3945/ajcn.113.06810624172306